{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:00:03Z","timestamp":1780401603881,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1797-9","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T05:54:43Z","timestamp":1492062883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The end of a dogma: the safety of doxycycline use in young children for malaria treatment"],"prefix":"10.1186","volume":"16","author":[{"given":"Tiphaine","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Briolant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylin","family":"Madamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"1797_CR1","unstructured":"WHO. World Malaria Report 2016. Geneva: World Health Organization; 2016."},{"key":"1797_CR2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/infdis\/jir664","volume":"204","author":"T Mita","year":"2011","unstructured":"Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, et al. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis. 2011;204:1980\u20138.","journal-title":"J Infect Dis"},{"key":"1797_CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature00813","volume":"418","author":"JC Wootton","year":"2002","unstructured":"Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320\u20133.","journal-title":"Nature"},{"key":"1797_CR4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"1797_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2015","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2015;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"1797_CR6","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/AAC.00835-15","volume":"59","author":"R Leang","year":"2015","unstructured":"Leang R, Taylor WR, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: Dihydroartemisinin\u2013Piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother. 2015;59:4719\u201326.","journal-title":"Antimicrob Agents Chemother"},{"key":"1797_CR7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","volume":"15","author":"MD Spring","year":"2015","unstructured":"Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin\u2013piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683\u201391.","journal-title":"Lancet Infect Dis."},{"key":"1797_CR8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin\u2013piperaquine\u00a0resistance\u00a0in Plasmodium falciparum malaria in\u00a0Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis."},{"key":"1797_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12936-016-1114-z","volume":"15","author":"T Gaillard","year":"2016","unstructured":"Gaillard T, Dormoi J, Madamet M, Pradines B. Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria. Malar J. 2016;15:85.","journal-title":"Malar J."},{"key":"1797_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12936-016-1613-y","volume":"15","author":"T Gaillard","year":"2016","unstructured":"Gaillard T, Madamet M, Foguim Tsombeng F, Dormoi J, Pradines B. Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? Malar J. 2016;15:556.","journal-title":"Malar J."},{"key":"1797_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","volume":"14","author":"T Gaillard","year":"2015","unstructured":"Gaillard T, Madamet M, Pradines B. Tetracyclines in malaria. Malar J. 2015;14:445.","journal-title":"Malar J."},{"key":"1797_CR12","unstructured":"CDC. Health information for international travel. Yellow book 2016. Atlanta: Centers for Diseases Control and Prevention; 2016."},{"key":"1797_CR13","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Recommandations sanitaires pour les voyageurs 2016. Bulletin Epid\u00e9miologique Hebdomadaire, hors s\u00e9rie, 2016."},{"key":"1797_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.medmal.2007.11.007","volume":"38","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise","year":"2008","unstructured":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise. Recommendations\u00a0for clinical practice Management and prevention of imported Plasmodium falciparum\u00a0malaria (Revision 2007 of the 1999 Consensus conference). Med Mal Infect. 2008;38:54\u201367.","journal-title":"Med Mal Infect."},{"key":"1797_CR15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","volume":"2","author":"DG Lalloo","year":"2016","unstructured":"Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJ, Chiodini PL. PHE Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines 2016. J Infect. 2016;2:635\u201349.","journal-title":"J Infect"},{"key":"1797_CR16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3201\/eid2007.140155","volume":"20","author":"N Hong Van","year":"2014","unstructured":"Van Hong N, Amambua-Ngwa A, Tuan NQ, Cuong do D, Giang NT, Van Dung N, et al. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2014;20:1199\u2013202.","journal-title":"Emerg Infect Dis"},{"key":"1797_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12936-017-1773-4","volume":"16","author":"S Diawara","year":"2017","unstructured":"Diawara S, Madamet M, Kounta MB, Lo G, Wade KA, Nakoulima A, et al. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015. Malar J. 2017;16:118.","journal-title":"Malar J."},{"key":"1797_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0049475515624857","volume":"46","author":"H Gupta","year":"2016","unstructured":"Gupta H, Dhunputh P, Bhatt AN, Satyamoorthy K, Umakanth S. Cerebral malaria in a man with Plasmodium vivax mono-infection: a case report. Trop Doct. 2016;46:241\u20135.","journal-title":"Trop Doct"},{"issue":"16","key":"1797_CR19","first-page":"30035","volume":"3876","author":"S Amireh","year":"2016","unstructured":"Amireh S, Shaaban H, Guron G. Severe Plasmodium vivax cerebral malaria complicated by hemophagocytic lymphohistiocytosis treated with\u00a0artesunate\u00a0and\u00a0doxycycline. Hematol Oncol Stem Cell Ther. 2016;3876(16):30035\u20138.","journal-title":"Hematol Oncol Stem Cell Ther."},{"key":"1797_CR20","first-page":"692","volume":"6","author":"H Shwachman","year":"1958","unstructured":"Shwachman H, Fekete E, Kulczycki LL, Foley GE. The effect of long-term antibiotic therapy in patients with cystic fibrosis of the pancreas. Antibiot Annu. 1958;6:692\u20139.","journal-title":"Antibiot Annu."},{"key":"1797_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/adc.42.223.311","volume":"42","author":"JN Swallow","year":"1967","unstructured":"Swallow JN, De Haller J, Young WF. Side-effects to antibiotics in cystic fibrosis: dental changes in relation to antibiotic administration. Arch Dis Child. 1967;42:311\u20138.","journal-title":"Arch Dis Child"},{"key":"1797_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/000992286300200607","volume":"2","author":"EV Zegarelli","year":"1963","unstructured":"Zegarelli EV, Denning CR, Kutscher AH, Fahn B, Kirschner G, Slaughter TW. Discoloration of\u00a0teeth\u00a0in patients with cystic fibrosis of the pancreas: role of\u00a0tetracycline\u00a0therapy. Clin Pediatr (Phila). 1963;2:329\u201331.","journal-title":"Clin Pediatr (Phila)."},{"key":"1797_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(62)91840-8","volume":"1","author":"IS Wallman","year":"1962","unstructured":"Wallman IS, Hilton HB. Teeth pigmented by tetracycline. Lancet. 1962;1:827\u20139.","journal-title":"Lancet"},{"key":"1797_CR24","first-page":"351","volume":"103","author":"JM Conchie","year":"1970","unstructured":"Conchie JM, Munroe JD, Anderson DO. The incidence of staining of permanent teeth by the tetracyclines. Can Med Assoc J. 1970;103:351\u20136.","journal-title":"Can Med Assoc J"},{"key":"1797_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(66)92683-3","volume":"2","author":"B Kowalewska","year":"1966","unstructured":"Kowalewska B, Szotowa W, Winiarska-Majczyno M. Tetracyclines and the\u00a0teeth. Lancet. 1966;2:387.","journal-title":"Lancet"},{"key":"1797_CR26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.14219\/jada.archive.1983.0111","volume":"106","author":"T Rebich","year":"1983","unstructured":"Rebich T, Kumar J, Brustman B. The St. Regis environmental health issue: assessment of dental defects. J Am Dental Assoc. 1983;106:630\u20133.","journal-title":"J Am Dental Assoc."},{"key":"1797_CR27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0022-3476(65)80407-3","volume":"67","author":"KH Ibsen","year":"1965","unstructured":"Ibsen KH, Urist MR, Sognnaes RF. Differences among tetracyclines with respect to the staining of teeth. J Pediatr. 1965;67:459\u201362.","journal-title":"J Pediatr"},{"key":"1797_CR28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(69)91787-5","volume":"1","author":"G Forti","year":"1969","unstructured":"Forti G, Beniucori C. Doxycycline and the teeth. Lancet. 1969;1:782.","journal-title":"Lancet"},{"key":"1797_CR29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/154405910508400703","volume":"84","author":"CJ Tredwin","year":"2005","unstructured":"Tredwin CJ, Scully C, Bagan-Sebastian JV. Drug-induced disorders of teeth. J Dent Res. 2005;84:596\u2013602.","journal-title":"J Dent Res"},{"key":"1797_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0006-291X(71)90660-7","volume":"43","author":"AH Caswell","year":"1971","unstructured":"Caswell AH, Hutchison JD. Selectivity of cation\u00a0chelation\u00a0to tetracyclines: evidence for special conformation of\u00a0calcium\u00a0chelate. Biochem Biophys Res Commun. 1971;43:625\u201330.","journal-title":"Biochem Biophys Res Commun"},{"key":"1797_CR31","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/00220345770560122201","volume":"56","author":"DB Lambrou","year":"1977","unstructured":"Lambrou DB, Tahos BS, Lambrou KD. In vitro studies of the phenomenon of\u00a0tetracycline\u00a0incorporation into enamel. J Dent Res. 1977;56:1527\u201332.","journal-title":"J Dent Res"},{"key":"1797_CR32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00006454-199805000-00019","volume":"17","author":"ME Lochary","year":"1998","unstructured":"Lochary ME, Lockhart PB, Williams WT. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J. 1998;17:429\u201331.","journal-title":"Pediatr Infect Dis J."},{"key":"1797_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0009922806290026","volume":"46","author":"B Volovitz","year":"2007","unstructured":"Volovitz B, Shkap R, Amir J, Calderon S, Varsano I, Nussinovitch M. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr. 2007;46:121\u20136.","journal-title":"Clin Pediatr"},{"key":"1797_CR34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","volume":"166","author":"SR Todd","year":"2015","unstructured":"Todd SR, Dahlgren S, Traeger MS, Beltran-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr. 2015;166:1246\u201351.","journal-title":"J Pediatr"},{"key":"1797_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mva.2002.125018","volume":"36","author":"BT Baxter","year":"2002","unstructured":"Baxter BT, Pearce WH, Waltke EA, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg. 2002;36:1\u201312.","journal-title":"J Vasc Surg"},{"key":"1797_CR36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","volume":"27","author":"K Smith","year":"2005","unstructured":"Smith K, Leyden JJ. Safety od doxycycline and minocycline: a systematic review. Clin Ther. 2005;27:1329\u201342.","journal-title":"Clin Ther"},{"key":"1797_CR37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","volume":"15","author":"R Cross","year":"2016","unstructured":"Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting\u00a0doxycycline\u00a0in pregnancy and early childhood\u2013time to rebuild its reputation? Expert Opin Drug Saf. 2016;15:367\u201382.","journal-title":"Expert Opin Drug Saf."},{"key":"1797_CR38","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jpeds.2015.03.019","volume":"166","author":"SS Long","year":"2015","unstructured":"Long SS. Good news about doxycycline and dental staining. J Pediatr. 2015;166:1101\u20134.","journal-title":"J Pediatr"},{"key":"1797_CR39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/106002809703100418","volume":"31","author":"DF Cale","year":"1997","unstructured":"Cale DF, McCarthy MW. Treatment of Rocky Mountain spotted fever in children. Ann Pharmacother. 1997;31:492\u20134.","journal-title":"Ann Pharmacother"},{"key":"1797_CR40","unstructured":"Anonymes. Addentum: Doxycycline for young children. Med Lett Drug Ther. 2016;58:82."},{"issue":"62","key":"1797_CR41","first-page":"1","volume":"2013","author":"CDC. Diagnosis and management of Q fever-United States","year":"2013","unstructured":"CDC. Diagnosis and management of Q fever-United States. Recommendations from CDC and the Q fever working group. MMWR Recomm Rep. 2013;2013(62):1\u201329.","journal-title":"MMWR Recomm Rep."},{"key":"1797_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","volume":"65","author":"HM Biggs","year":"2016","unstructured":"Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep. 2016;65:1\u201344.","journal-title":"MMWR Recomm Rep."},{"key":"1797_CR43","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd edition. Geneva: World Health Organization; 2015."},{"key":"1797_CR44","first-page":"CD003756","volume":"15","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for\u00a0malaria\u00a0in children living in areas with seasonal transmission. Cochrane Database System Rev. 2012;15:CD003756.","journal-title":"Cochrane Database System Rev."},{"key":"1797_CR45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12936-015-0988-5","volume":"14","author":"JR Matangila","year":"2015","unstructured":"Matangila JR, Mitashi P, Inoc\u00eancio da Luz RA, Lutumba PT, Van Geertruyden JP. Efficacy and safety of intermittent preventive treatment for malaria in schoolchildren: a systematic review. Malar J. 2015;14:450.","journal-title":"Malar J."},{"key":"1797_CR46","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/cid\/ciu150","volume":"58","author":"JI Nankabirwa","year":"2014","unstructured":"Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, et al. Impact of intermittent preventive treatment with dihydroartemisinin\u2013piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis. 2014;58:1404\u201312.","journal-title":"Clin Infect Dis"},{"key":"1797_CR47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4269\/ajtmh.2004.71.732","volume":"71","author":"SE Clarke","year":"2004","unstructured":"Clarke SE, Brooker S, Njagi JK, Njau E, Estambale B, Muchiri E, et al. Malaria morbidity among school children living in two areas of contrasting transmission in western Kenya. Am J Trop Med Hyg. 2004;71:732\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1797_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(08)61034-X","volume":"372","author":"SE Clarke","year":"2008","unstructured":"Clarke SE, Jukes MC, Njagi JK, Khasakhala L, Cundill B, Otido J, et al. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:127\u201338.","journal-title":"Lancet"},{"key":"1797_CR49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1475-2875-7-123","volume":"7","author":"A Dicko","year":"2008","unstructured":"Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, Kone M, et al. Impact of intermittent preventive treatment with sulphadoxine\u2013pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J. 2008;7:123.","journal-title":"Malar J."},{"key":"1797_CR50","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-3156.2009.02294.x","volume":"14","author":"B Barger","year":"2009","unstructured":"Barger B, Maiga H, Traore OB, Tekete M, Tembine I, Dara A, et al. Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali. Trop Med Int Health. 2009;14:784\u201391.","journal-title":"Trop Med Int Health."},{"key":"1797_CR51","doi-asserted-by":"crossref","first-page":"e13438","DOI":"10.1371\/journal.pone.0013438","volume":"5","author":"J Nankabirwa","year":"2010","unstructured":"Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS ONE. 2010;5:e13438.","journal-title":"PLoS ONE"},{"key":"1797_CR52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1475-2875-10-358","volume":"10","author":"RC Tine","year":"2011","unstructured":"Tine RC, Faye B, Ndour CT, Ndiaye JL, Ndiaye M, Bassene C, et al. Impact of combining intermittent preventive treatment with home management of\u00a0malaria\u00a0in children less than 10\u00a0years in a rural area of Senegal: a cluster randomized trial. Malar J. 2011;10:358.","journal-title":"Malar J."},{"key":"1797_CR53","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1128\/AAC.00394-06","volume":"50","author":"EL Dahl","year":"2006","unstructured":"Dahl EL, Shock JL, Shenai BR, Gut J, DeRisi JL, Rosenthal PJ. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother. 2006;50:3124\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"1797_CR54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1475-2875-9-141","volume":"9","author":"S Briolant","year":"2010","unstructured":"Briolant S, Almeras L, Belghazi M, Boucomont-Chapeaublanc E, Wurtz N, Fontaine JC, et al. Plasmodium falciparum proteome changes in response to doxycycline treatment. Malar J. 2010;9:141.","journal-title":"Malar J."},{"key":"1797_CR55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65:232\u201360.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1797_CR56","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1473-3099(13)70179-8","volume":"13","author":"E Angelakis","year":"2013","unstructured":"Angelakis E, Merhej V, Raoult D. Related actions of probiotics and antibiotics on gut\u00a0microbiota\u00a0and weight modification. Lancet Infect Dis. 2013;13:889\u201399.","journal-title":"Lancet Infect Dis."},{"key":"1797_CR57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature18849","volume":"535","author":"AJ B\u00e4umler","year":"2016","unstructured":"B\u00e4umler AJ, Sperandio V. Interactions between the\u00a0microbiota\u00a0and pathogenic bacteria in the gut. Nature. 2016;535:85\u201393.","journal-title":"Nature"},{"key":"1797_CR58","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/AAC.02437-14","volume":"58","author":"E Angelakis","year":"2014","unstructured":"Angelakis E, Million M, Kankoe S, Lagier JC, Armougom F, Giorgi R, et al. Abnormal weight gain and gut\u00a0microbiota\u00a0modifications are side effects of long-term doxycycline and hydroxychloroquine treatment. Antimicrob Agents Chemother. 2014;58:3342\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1797_CR59","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(88)92710-9","volume":"2","author":"DN Taylor","year":"1988","unstructured":"Taylor DN, Pitarangsi C, Echeverria P, Diniega BM. Campylobacter enteritis during doxycycline prophylaxis for malaria in Thailand. Lancet. 1988;2:578\u20139.","journal-title":"Lancet"},{"key":"1797_CR60","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4269\/ajtmh.1990.43.608","volume":"43","author":"JD Arthur","year":"1990","unstructured":"Arthur JD, Echeverria P, Shanks GD, Karwacki J, Bodhidatta L, Brown JE. A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis. Am J Trop Med Hyg. 1990;43:608\u201313.","journal-title":"Am J Trop Med Hyg"},{"key":"1797_CR61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2334-13-68","volume":"13","author":"TJ Vento","year":"2013","unstructured":"Vento TJ, Cole DW, Mende K, Calvano TP, Rini EA, Tully C, et al. Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis. 2013;13:68.","journal-title":"BMC Infect Dis"},{"key":"1797_CR62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/1471-2334-13-325","volume":"13","author":"TJ Vento","year":"2013","unstructured":"Vento TJ, Cole DW, Mende K, Calvano TP, Rini EA, Tully C, et al. Staphylococcus aureus colonization of healthy military service members in the United States and Afghanistan. BMC Infect Dis. 2013;13:325.","journal-title":"BMC Infect Dis"},{"key":"1797_CR63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3201\/eid1303.060729","volume":"13","author":"O Lesens","year":"2007","unstructured":"Lesens O, Haus-Cheymol R, Dubrous P, Verret C, Spiegel A, Bonnet R, et al. Methicillin-susceptible, doxycycline-resistant Staphylococcus aureus, C\u00f4te d\u2019Ivoire. Emerg Infect Dis. 2007;13:488\u201390.","journal-title":"Emerg Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T01:07:10Z","timestamp":1569028030000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1797-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1797-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]},"article-number":"148"}}